Get started
Porsche: Ready to Race?Instead of stepping on the gas pedal, the Porsche stock corrected as soon as it touched our tourqoise target zone. We predict that the course continues to drop into the red zone between 56.44€ and 44.06€, until it completes the red wave (2). Following the correction, the trend should head towards the resistance at 69.20€. In an alternative scenario with a 35% chance, the Porsche stock has the opportunity to push for a rapid turnaround now and exceed the 69.20€ resistance mark to gain further pace on the upper side.
XETR:PAH3Short
by MarketIntel
Volkswagen (VOW3.de) bullish scenario:The technical figure Triangle can be found in the daily chart in the German company Volkswagen AG (VOW3.de). Volkswagen AG, known internationally as the Volkswagen Group, is a German multinational automotive manufacturer. The company designs, manufactures and distributes passenger and commercial vehicles, motorcycles, engines and turbomachinery, as well as offering related services, including financing, leasing and fleet management. In 2016, it was the world's largest automaker by sales, and keeping this title in 2017, 2018 and 2019, selling 10.9 million vehicles. It has maintained the largest market share in Europe for over two decades. It ranked seventh in the 2020 Fortune Global 500 list of the world's largest companies. The Triangle broke through the resistance line on 02/11/2022. If the price holds above this level, you can have a possible bullish price movement with a forecast for the next 9 days towards 141.98 EUR. Your stop-loss order, according to experts, should be placed at 125.40 EUR if you decide to enter this position. VW reported $4.3 billion in third quarter operating profit. Wall Street was looking for $4.5 billion. Shares are down 3.8% in overseas trading. Financial guidance hasn’t changed, but delivery guidance has. Back in July, Volkswagen believed total deliveries in 2022 would rise 5% to 10% compared with the 2021 total of 8.9 million units. Now the company expects 2022 deliveries to be the same as 2021. Supply chain constraints are to blame. Despite that headwind VW’s EV business continued to expand in the quarter. Battery electric vehicles amounted to 6.8% of total VW deliveries. Year to date, VW has delivered 366,400 EVs, up from 293,000 delivered in the same period of 2021. China accounted for 112,700 of those 2022 EV deliveries. VW’s Chinese EV sales are up 139% so far in 2022 compared with the same span of 2021. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
XETR:VOW3Long
by legacyFXofficial
Broadening rising wedge - and company future perspectiveAfter the DMP Stock touched and rebounced from it's 52-Week support at 36,00€, it is now creating a broadening rising wedge formation. As from market perspective, this formation can be attributed to high uncertainty as well as worsening growth perspective for the Euro-Zone. Mid-term perspective for the stock is bearish. Rising broadening wedge will most probably break downwards and reach statgnation at support (36,00€). Nevertheless, this formation can be exploited to do swing-traiding. Keep in mind, that a negative forecast on the quarterly earnings report would most probably send the stock on a downwards tumble. The acquisition of the french company Arkopharma in early August shows the general spirit of diversification from the predominantly COVID19-vaccine based earnings in 2021 towards it's historical core business (patent-free drugs). This earnings report could very well give the longterm oriented investors an insight in the challenges or succeses that Dermapharm is facing at integrating the freshly acquired Arkopharma and thus give clarity (which would most likely lead to lower volatility figures). Generally speaking, at a P/E ratio of under 12 and a current dividend yield of over 5%, all 5 analysts agree on a "BUY" recomendation.
XETR:DMPLong
by nicolasbn
Adidas - Outlook downgrade supports a bearish thesis Adidas is another company confirming what we laid out some time ago - a trouble brewing during the current earning season, supporting our notion about the stock market progressing in the second stage of the downtrend. That being said, the company reported its quarterly earnings, after which the stock fell approximately 10%. The report highlighted deteriorating demand and adjustment of the outlook for the rest of 2022 while also pointing out a build-up in inventories. We expect the same trend to continue among other companies and strengthen during the next earning season concerning Q4 2022. Therefore, we voice a word of caution to investors as this will lead the market slowly but surely into the 3rd stage of the bear market. Illustration 1.01 Moving averages continue to reflect the bearish conditions on the daily chart of Adidas stock. Technical analysis - daily time frame RSI, MACD, Stochastic, DM+, and DM- are all bearish. Overall, the weekly time frame is bearish but also reaching oversold levels for the short term. Illustration 1.02 The weekly chart of Adidas also shows bearish conditions between two moving averages. However, the price deviated too far from the 20-week SMA, making a case for a short-term bounce toward it. Technical analysis - weekly time frame RSI, MACD, Stochastic, DM+, and DM- are all bearish. Overall, the weekly time frame is bearish but also reaching oversold levels for the short term. Please feel free to express your ideas and thoughts in the comment section. DISCLAIMER: This analysis is not intended to encourage any buying or selling of any particular securities. Furthermore, it should not be a basis for taking any trade action by an individual investor. Therefore, your own due diligence is highly advised before entering a trade.
XETR:ADSShort
by Tradersweekly
14
longterm buy, short-term sell After the complete 1-5 Elliot-Wave and the correction wave Bayer is still not in an upward trend. Despite Bayer's technical improvement, the stock is still not in an upward trend, and lower lows are not excluded in the coming quarters. Currently, it appears that Bayer is beginning to move higher, and €46 in October may have represented a bottom. Although we shouldn't get too excited yet, since Bayer isn't technically in an upward trend until the stock moves above the last high of €74 (June 2020) and, ideally, also above the pre-pandemic high of €78. As year is coming close to an end and macroeconomic situation is not at its best, I expect the a bottom touch of €40 before it goes longterm up in the spring of 2023.
XETR:BAYNLong
by Pimmixx